Conduct study P215
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,538,009
Award facts
- Opportunity
-
- 0033 Solicitation number
- Steel, Forging Die Block Pre-Solicitation · Posted Nov 16, 2018
- Contract value 81% obligated
-
- $1,538,009.00 Current, with exercised options
- $1,887,979.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $532,654 | |
| Change Order | $65,521 | |
| Funding Only Action | $251,179 | |
| Other Administrative Action | $0 | |
| Change Order | $157,696 | |
| Change Order | $0 | |
| Original award | $530,959 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Bioqual, Inc. a delivery order valued at $1.89M for conducting Study P215 under the Simian Vaccine Evaluation Units (SVEUS) program. This contract, which commenced on September 8, 2021 and is scheduled for completion by August 25, 2026, employs a cost-plus-fixed-fee pricing structure and is not set aside for any particular business category. The work will be performed in Potomac, Maryland, and represents a task order against NIAID's broader SVEUS indefinite delivery contract vehicle focused on developing and evaluating animal models for infectious disease countermeasures.
Bioqual, a Rockville-based biomedical research services company with extensive experience supporting federal research agencies since 1999, is well-positioned to execute this assignment. The company specializes in providing advanced preclinical research support, including non-human primate studies essential to vaccine development and infectious disease research. This delivery order aligns with NIAID's mission to support critical research infrastructure for evaluating potential medical countermeasures through sophisticated animal model systems, and reflects Bioqual's established expertise in conducting specialized studies involving primate research and laboratory analysis for the institute.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Bioqual, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 8, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $1,538,009 on 75N93021F00001. Its potential value, with all options, is $1,887,979.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93020D00006, an indefinite delivery contract, on Simian Vaccine Evaluation Units.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award